The production of plastic has reached over 400 million tons annually, leading to significant environmental pollution, affecting ecosystems from beaches to the ocean's depths. This widespread use also contributes to climate change, with plastic production generating an estimated 1.8 billion tons of greenhouse gases each year. Moreover, microplastics—tiny particles resulting from the breakdown of plastic items—have been found in a variety of human biological samples, including blood and breast milk, raising concerns about their impact on human health.
Recent research published in the journal Osteoporosis International highlights the potential health risks associated with microplastics, particularly regarding bone health. Conducted by a team at the Faculty of Medical Sciences of the State University of Campinas in Brazil, the study reviewed 62 scientific articles and identified mechanisms through which microplastics could harm bone tissue. Notably, microplastics may affect bone marrow stem cells, leading to an increase in osteoclasts, which are responsible for bone resorption.
Rodrigo Bueno de Oliveira, the study's coordinator, noted that in vitro studies have demonstrated that microplastics can impair cell viability and promote inflammation, while animal studies suggest that exposure might compromise bone structure and growth. The implications of these findings are significant, especially as the prevalence of osteoporosis-related fractures is projected to increase by 32% by 2050, according to the International Osteoporosis Foundation.
Oliveira's team is initiating further research to investigate the link between microplastics and metabolic bone diseases using animal models. Their aim is to explore whether microplastics could be a controllable environmental factor contributing to rising rates of bone fractures, thereby enhancing the understanding of osteometabolic diseases and informing future public health strategies.